This is an intersectional and interdisciplinary screening program in Viborg Municipality, including 67 years old citizens. This observational study will estimate the cost-effectiveness of a combined screening program for the following conditions: Abdominal aortic aneurysm, peripheral arterial disease, carotid plaque, hypertension, arrhythmia, and type-2-diabetes. Furthermore, the incidence of the outlined conditions will be described and so will the result of the intervention initiated (secondary medical prophylaxis, smoking cessation, introduction to nutritionally deficient diet etc.)
Age range
67 Years – 67 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Baseline prevalence of peripheral arterial disease (PAD) in men and women aged 67 years from a population screening study on the Municipal of Viborg.
Timeframe: Inclusion will take place from sep. 2014 to sep. 2020
Baseline prevalence of abdominal aortic aneurysm (AAA)
Timeframe: Inclusion will take place from sep. 2014 to sep. 2020
Baseline prevalence of diabetes
Timeframe: Inclusion will take place from sep. 2014 to sep. 2020
Baseline prevalence of hypertension
Timeframe: Inclusion will take place from sep. 2014 to sep. 2020
Baseline prevalence of cardiac arrythmia
Timeframe: Inclusion will take place from sep. 2014 to sep. 2020
Baseline prevalence of carotic plaques
Timeframe: Inclusion will take place from sep. 2014 to sep. 2020